Description
An allosteric antagonist of PAR2; inhibits SLIGRL-induced calcium mobilization by wild-type and 10 mutant forms of PAR2 in a FLIPR assay (IC50s = 23 and 12-780 nM, respectively); selective for PAR2 over PAR4 and PAR1 (IC50s = 50,000 nM, respectively, in a β-arrestin-2 recruitment assay); inhibits SLIGRL-induced phosphorylation of ERK in 1321N1 astrocytoma cells at 10 µM
Formal name: 2-(6-bromo-1,3-benzodioxol-5-yl)-N-(4-cyanophenyl)-1-[(1S)-1-cyclohexylethyl]-1H-benzimidazole-5-carboxamide
Synonyms:
Molecular weight: 571.5
CAS: 2100284-59-9
Purity: ≥98%
Formulation: A solid